April Eichler Selected Research

Nivolumab

10/2021

Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

April Eichler Research Topics

Disease

1	Meningeal Carcinomatosis 10/2021
1	Gastritis 01/2019
1	Exanthema (Rash) 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Brain Neoplasms (Brain Tumor) 04/2014
1	Neoplasm Metastasis (Metastasis) 04/2014
1	Breast Neoplasms (Breast Cancer) 04/2014
1	Neutropenia 03/2013
1	Fatigue 03/2013
1	Glioma (Gliomas) 03/2013
1	Neoplasms (Cancer) 03/2013

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 01/2019 - 03/2013
1	NivolumabIBA 10/2021
1	IpilimumabIBA 10/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2019
1	EnzymesIBA 01/2019
1	iniparibIBA 01/2019
1	epothilone B (EPO906)IBA 04/2014
1	Peptides (Polypeptides)IBA 03/2013
1	paclitaxel-Angiopep-2 conjugateIBA 03/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2013
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 03/2013

Therapy/Procedure

2	Radiotherapy 01/2019 - 04/2014
1	Therapeutics 03/2013